Prevalence of anemia and its impact on mortality and hospitalization rate in predialysis patients and the prepare study group

Nephron - Clinical Practice

Volumn 115, Issue 2, 2010, Pages

  Voormolen, N ^a   Grootendorst, D C ^a   Urlings, T A J ^a   Boeschoten, E W ^b   Sijpkens, Y W ^a   Huisman, R M ^c   Krediet, R T ^d   Dekker, F W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hans Mak Institute   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Anemia; Chronic kidney disease stage 4 5; Predialysis

Indexed keywords

ALBUMIN; HEMOGLOBIN; IRON; PHOSPHATE; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; COMMUNITY HOSPITAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NETHERLANDS; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RENOVASCULAR DISEASE; RISK FACTOR; UNIVERSITY HOSPITAL;

ADULT; AGED; ANEMIA; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 77951027172     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000312876     Document Type: Article

References (35)

1. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held PJ, Port FK: Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 94-111. (Pubitemid 38880932)
2. Valderrabano F, Horl WH, Macdougall IC, Rossert J, Rutkowski B, Wauters JP: PRE-dialysis survey on anaemia management. Nephrol Dial Transplant 2003; 18: 89-100.
3. Robinson BE: Epidemiology of chronic kidney disease and anemia. J Am Med Dir Assoc 2006; 7:S3-S6.
4. Li S, Foley RN, Collins AJ: Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease. Int Urol Nephrol 2005; 37: 395-402.
5. Vlagopoulos PT, Tighiouart H, Weiner DE, Griffith J, Pettitt D, Salem DN, Levey AS, Sarnak MJ: Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol 2005; 16: 3403-3410.
6. Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 2005; 16: 1803-1810.
7. Levin A, Djurdjev O, Duncan J, Rosenbaum D, Werb R: Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 2006; 21: 370-377.
8. Lu WX, Jones-Burton C, Zhan M, Salzberg DJ, Moore J Jr, Fink JC: Survival benefit of recombinant human erythropoietin administration prior to onset of end-stage renal disease: variations across surrogates for quality of care and time. Nephron Clin Pract 2005; 101:c79-c86.
9. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098.
10. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084.
11. Macdougall IC, Temple RM, Kwan JT: Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, openlabel, prospective, randomized, comparative group trial. Nephrol Dial Transplant 2007; 22: 784-793.
12. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D: Anaemia of CKD - the CHOIR study revisited. Nephrol Dial Transplant 2007; 22: 1806-1810.
13. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant 1999; 14(suppl 5):1-50.
14. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001; 37:S182-S238.
15. Kausz AT, Solid C, Pereira BJ, Collins AJ, St Peter W: Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease? Am J Kidney Dis 2005; 45: 136-147.
16. Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ: Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 121-132. (Pubitemid 38072623)
17. Ofsthun N, Labrecque J, Lacson E, Keen M, Lazarus JM: The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int 2003; 63: 1908-1914.
18. Levin A, Djurdjev O, Thompson C, Barrett B, Ethier J, Carlisle E, Barre P, Magner P, Muirhead N, Tobe S, Tam P, Wadgymar JA, Kappel J, Holland D, Pichette V, Shoker A, Soltys G, Verrelli M, Singer J: Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 2005; 46: 799-811.
19. Holland DC, Lam M: Predictors of hospitalization and death among predialysis patients: a retrospective cohort study. Nephrol Dial Transplant 2000; 15: 650-658.
20. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002; 162: 1401-1408. (Pubitemid 34655201)
21. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39:S1-S200.
22. Jungers PY, Robino C, Choukroun G, Nguyen- Khoa T, Massy ZA, Jungers P: Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients. Nephrol Dial Transplant 2002; 17: 1621-1627.
23. ERA-EDTA Registry 2005 Annual Report. Amsterdam, Academic Medical Center, Department of Medical Informatics, 2007.
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
25. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM: Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415-418.
26. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M: The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 2004; 20: 1501-1510. (Pubitemid 39361354)
27. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590.
28. Strippoli GF, Craig JC, Manno C, Schena FP: Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2004; 15: 3154-3165.
29. Strippoli GF, Navaneethan SD, Craig JC: Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database Syst Rev 2006; 4: CD003967.
30. Rossert JA, McClellan WM, Roger SD, Verbeelen DL, Horl WH: Contribution of anaemia to progression of renal disease: a debate. Nephrol Dial Transplant 2002; 17(suppl 1):60-66.
31. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE: Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int 2006; 69: 560-564.
32. John R, Webb M, Young A, Stevens PE: Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004; 43: 825-835.
33. Stenvinkel P: Anaemia and inflammation: what are the implications for the nephrologist? Nephrol Dial Transplant 2003; 18(suppl 8):viii17-viii22.
34. Foley RN, Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 1998; 11: 239-245.
35. Stevens P: Optimizing renal anaemia management - benefits of early referral and treatment. Nephrol Dial Transplant 2005; 20(suppl 8):viii22-viii26.